» Authors » Daniel Sidler

Daniel Sidler

Explore the profile of Daniel Sidler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 801
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bocchi F, Muller S, Binet I, Golshayan D, Haidar F, Muller T, et al.
Kidney Int Rep . 2025 Feb; 10(2):565-573. PMID: 39990912
Introduction: Most of Switzerland's population and employment opportunities are concentrated in urban areas. Although kidney transplantation (KT) is the preferred therapy for eligible candidates, individuals in rural areas face challenges...
2.
Kuhn C, Janigen B, Matuschik L, Rieger M, Sidler D, Zschiedrich S
BMC Nephrol . 2025 Feb; 26(1):59. PMID: 39915729
Background: Despite advances in kidney transplant surgery and immunosuppression, lymphoceles remain a frequent complication in the early postoperative period following kidney transplantation, often requiring reintervention. While long-term outcomes such as...
3.
Bertacchi M, Ferrari-Lacraz S, Nilsson J, Thaqi A, Schmutz Y, Wehmeier C, et al.
Front Public Health . 2025 Jan; 12():1500781. PMID: 39845654
Introduction: The Swiss allocation system for kidney transplantation has evolved over time to balance medical urgency, immunological compatibility, and waiting time. Since the introduction of the transplantation law in 2007,...
4.
Schwab S, Steck H, Binet I, Elmer A, Ender W, Franscini N, et al.
PLOS Digit Health . 2024 Dec; 3(12):e0000691. PMID: 39693311
Deceased-donor kidney allografts are exposed to ischemic injury during ex vivo transport due to the lack of blood oxygen supply. Hypothermic machine perfusion (HMP) effectively reduces the risk of delayed...
5.
Kusejko K, Kouyos R, Bernasconi E, Boggian K, Braun D, Calmy A, et al.
BMC Infect Dis . 2024 Oct; 24(1):1143. PMID: 39394577
Background: Since the implementation of universal antiretroviral therapy, kidney transplantation (K-Tx) has become a valuable option for treatment of end-stage kidney disease for people with HIV (PWH) with similar patient...
6.
Schwab S, Elmer A, Sidler D, Straumann L, Sturzinger U, Immer F
JAMA Netw Open . 2024 Sep; 7(9):e2432415. PMID: 39254975
Importance: Median organ waiting times published by transplant organizations may be biased when not appropriately accounting for censoring, death, and competing events. This can lead to overly optimistic waiting times...
7.
Bocchi F, Schietzel S, Huynh-Do U, Vogt B, Sidler D
Front Nephrol . 2024 Jul; 4:1385447. PMID: 39081661
Background: In kidney transplant (KT) patients, magnesium (Mg) deficiency is widespread. It is often encountered early after KT, may persist longer, and is frequently promoted by calcineurin inhibitors (CNIs) and...
8.
Bocchi F, Beldi G, Kuhn C, Storni F, Muller N, Sidler D
Front Transplant . 2024 Jul; 2:1240155. PMID: 38993921
Introduction: The demographics of donor and recipient candidates for kidney transplantation (KT) have substantially changed. Recipients tend to be older and polymorbid and KT to suboptimal recipients is associated with...
9.
de Vos C, de Vos W, Widemann-Grolig A, van Wyk L, Sidler D, Goussard P
Eur J Pediatr . 2024 Jun; 183(9):3777-3783. PMID: 38864876
Surgically repaired esophageal atresia (EA) is associated with chronic esophageal and respiratory morbidity that require ongoing management. The care of chronically ill children can exert considerable stress on parents, thereby...
10.
Hammer N, Hoessly L, Haidar F, Hirzel C, de Seigneux S, Van Delden C, et al.
Transpl Int . 2024 May; 37:12712. PMID: 38784442
Valganciclovir (VGC) is administered as prophylaxis to kidney transplant recipients (KTR) CMV donor (D)+/recipient (R)- and CMV R+ after thymoglobulin-induction (R+/TG). Although VGC dose adjustments based on renal function are...